Blackshear M A, Sanders-Bush E
J Pharmacol Exp Ther. 1982 May;221(2):303-8.
The chronic administration of mianserin for 14 days leads to a marked decrease in the maximal number of serotonin2 (5-HT2) binding sites in brains of rats and mice with no change in the KD values. The decrease in [3H]spiroperidol binding to the 5-HT2 site in rats was most pronounced in the frontal cortex with only minor changes in hippocampus and pons-medulla. The 5-HT1 site was largely unaffected. The decrease in the Bmax for 5-HT2 site also occurred after a single dose of mianserin, although mianserin was more potent when given chronically. Maximal inhibition of binding occurred with a chronic dose of 0.5 mg/kg. The greatest decrease was found 48 hr after single or repeated doses with a gradual return to normal levels within 10 days. The administration of mianserin also leads to a decrease in 5-methoxy-N,N-dimethyltryptamine-induced head twitches in mice assayed 48 and 96 hr after a single or repeated doses, which is presumably correlated with the decrease in the 5-HT2 binding site assayed in vitro.
连续14天给予米安色林会导致大鼠和小鼠大脑中5-羟色胺2(5-HT2)结合位点的最大数量显著减少,而解离常数(KD值)没有变化。在大鼠中,[3H]螺哌啶醇与5-HT2位点的结合减少在额叶皮质最为明显,海马体和脑桥-延髓仅有轻微变化。5-HT1位点基本未受影响。单剂量米安色林后也会出现5-HT2位点最大结合量(Bmax)的减少,尽管米安色林长期给药时效力更强。慢性剂量为0.5mg/kg时出现最大结合抑制。单次或重复给药后48小时发现结合减少最为明显,10天内逐渐恢复到正常水平。米安色林给药还会导致单次或重复给药后48小时和96小时检测的小鼠中5-甲氧基-N,N-二甲基色胺诱导的头部抽搐减少,这可能与体外检测的5-HT2结合位点减少有关。